Article ID Journal Published Year Pages File Type
3851846 American Journal of Kidney Diseases 2008 14 Pages PDF
Abstract
With intensive lowering of LDL-C levels for 1 year, hemodialysis patients treated with either calcium acetate or sevelamer experienced similar progression of CAC.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Preview
A 1-Year Randomized Trial of Calcium Acetate Versus Sevelamer on Progression of Coronary Artery Calcification in Hemodialysis Patients With Comparable Lipid Control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) Study
Authors
, , , , , , , ,